Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

2.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.4K
Aging01:26

Aging

174
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
174
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Bone Disorders01:29

Bone Disorders

3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Integration of geriatric assessment-guided care plan modifications and interventions into clinical paths of older adults with cancer (GORILLA): a feasibility approach.

European geriatric medicine·2026
Same author

Comment on "Transcutaneous auricular vagus nerve stimulation for prevention of postoperative cognitive dysfunction in older adults with gastrointestinal tumors: A randomized controlled trial".

Journal of geriatric oncology·2026
Same author

Dysphagia as a geriatric syndrome: nationwide outcomes from the GEMIDAS registry.

Archives of gerontology and geriatrics·2026
Same author

Multifeature endoscopic swallowing patterns associated with pneumonia in hospitalized geriatric patients: a four-year longitudinal cohort study.

BMC geriatrics·2026
Same author

Zeitschrift fur Gerontologie und Geriatrie·2026
Same author

MNA-SF screening and GLIM diagnosis of malnutrition in geriatric patients - A cross-sectional multicenter study.

The journal of nutrition, health & aging·2026

Video Experimental Relacionado

Updated: Sep 8, 2025

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

660

[Fragilidad en oncogeriatría]

Nina Rosa Neuendorff1, Rainer Wirth2, Barbara Deschler-Baier3

  • 1Klinik für Altersmedizin und Frührehabilitation, Marien Hospital Herne, Klinikum der Ruhr-Universität Bochum, Hölkeskampring 40, 44625, Herne, Deutschland. ninarosa.neuendorff@elisabethgruppe.de.

Innere Medizin (Heidelberg, Germany)
|September 5, 2025
PubMed
Resumen

La fragilidad es común en pacientes mayores con cáncer, lo que afecta los resultados. La evaluación oncogeriátrica con manejo (GAME) ayuda a detectar y manejar la fragilidad, reduciendo las toxicidades y mejorando la finalización del tratamiento y la calidad de vida.

Palabras clave:
El cáncerAdultos mayores frágilesEvaluación geriátricaEn el campo de la oncologíaTolerancia al tratamiento

Más Videos Relacionados

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.7K
Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

3.1K

Videos de Experimentos Relacionados

Last Updated: Sep 8, 2025

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

660
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.7K
Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

3.1K

Área de la Ciencia:

  • Oncología Geriátrica
  • Cuidado del cáncer
  • Investigación sobre el envejecimiento

Sus antecedentes:

  • La fragilidad es un síndrome geriátrico prevalente en adultos mayores con cáncer, que influye significativamente en el pronóstico y la tolerancia al tratamiento.
  • Los factores de riesgo compartidos entre la fragilidad y el cáncer están relacionados con las características del envejecimiento.
  • Las deficiencias geriátricas a menudo coexisten con la fragilidad en pacientes con cáncer.

Objetivo del estudio:

  • Revisar la definición y el significado de la fragilidad física y social en oncología.
  • Evaluar la evidencia que apoya el enfoque de la evaluación oncogeriátrica con gestión (GAME).
  • Resumir los hallazgos iniciales sobre estrategias de tratamiento del cáncer adaptadas a la fragilidad.

Principales métodos:

  • Revisión de la literatura existente sobre la fragilidad en la oncología geriátrica.
  • Análisis de los componentes y beneficios del modelo GAME.
  • Síntesis de los resultados de los estudios que aplican tratamientos adaptados a la fragilidad.

Principales resultados:

  • GAME identifica efectivamente la fragilidad y los problemas geriátricos asociados en pacientes con cáncer.
  • La aplicación de GAME se asocia con una reducción de las toxicidades relacionadas con el tratamiento.
  • GAME demuestra potencial para mejorar las tasas de finalización del tratamiento contra el cáncer y la calidad de vida de los pacientes.

Conclusiones:

  • La evaluación oncogeriátrica con gestión (GAME) es una herramienta valiosa para optimizar la atención del cáncer en adultos mayores frágiles.
  • Abordar la fragilidad a través de GAME puede mitigar las complicaciones del tratamiento y mejorar los resultados del paciente.
  • Los enfoques de tratamiento adaptados a la fragilidad son prometedores para mejorar la experiencia general de atención de los pacientes con cáncer de edad avanzada.